Share

November 26, 2013; 81 (22) Correction

Evidence-based guideline: Treatment of tardive syndromes: Report of the Guideline Development Subcommittee of the American Academy of Neurology

First published November 25, 2013, DOI: https://doi.org/10.1212/01.wnl.0000436080.72985.b0
Full PDF
Citation
Permissions

Make Comment

See Comments

Downloads
584

Share

See original article:

In the evidence-based guideline “Treatment of tardive syndromes: Report of the Guideline Development Subcommittee of the American Academy of Neurology” by R. Bhidayasiri et al. (Neurology® 2013;81:463–469), there was an error in table e-1; the corrected version was posted with the article on September 4, 2013. In addition, 2 studies were inadvertently excluded from the literature search (and thus from the guideline). The following references should have been cited. The authors regret the errors.

References

  1. 1.
    1. Lerner V,
    2. Miodownik C,
    3. Kaptsan A,
    4. et al
    . Vitamin B6 treatment for tardive dyskinesia: a randomized, double-blind, placebo-controlled, crossover study. J Clin Psychiatry 2007;68:1648–1654.
    OpenUrlCrossRefPubMed
  2. 2.
    1. Libov I,
    2. Miodownik C,
    3. Bersudsky Y,
    4. et al
    . Efficacy of piracetam in the treatment of tardive dyskinesia in schizophrenic patients: a randomized, double-blind, placebo-controlled crossover study. J Clin Psychiatry 2007;68:1031–1037.
    OpenUrlPubMed

Disputes & Debates: Rapid online correspondence

No comments have been published for this article.
Comment

NOTE: All authors' disclosures must be entered and current in our database before comments can be posted. Enter and update disclosures at http://submit.neurology.org. Exception: replies to comments concerning an article you originally authored do not require updated disclosures.

  • Stay timely. Submit only on articles published within the last 8 weeks.
  • Do not be redundant. Read any comments already posted on the article prior to submission.
  • 200 words maximum.
  • 5 references maximum. Reference 1 must be the article on which you are commenting.
  • 5 authors maximum. Exception: replies can include all original authors of the article.
  • Submitted comments are subject to editing and editor review prior to posting.

More guidelines and information on Disputes & Debates

Compose Comment

More information about text formats

Plain text

  • No HTML tags allowed.
  • Web page addresses and e-mail addresses turn into links automatically.
  • Lines and paragraphs break automatically.
Author Information
NOTE: The first author must also be the corresponding author of the comment.
First or given name, e.g. 'Peter'.
Your last, or family, name, e.g. 'MacMoody'.
Your email address, e.g. higgs-boson@gmail.com
Your role and/or occupation, e.g. 'Orthopedic Surgeon'.
Your organization or institution (if applicable), e.g. 'Royal Free Hospital'.
Publishing Agreement
NOTE: All authors, besides the first/corresponding author, must complete a separate Disputes & Debates Submission Form and provide via email to the editorial office before comments can be posted.
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.

Vertical Tabs

You May Also be Interested in

Back to top
Advertisement

Related Articles

Alert Me